A Multicenter, Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium) When Used in Routine Medical Practice in Korea
Latest Information Update: 17 Jul 2024
At a glance
- Drugs Nusinersen (Primary)
- Indications Spinal muscular atrophy
- Focus Adverse reactions
- Acronyms STANDARD
- Sponsors Biogen
Most Recent Events
- 05 Oct 2020 Planned End Date changed from 11 May 2022 to 1 Jul 2027.
- 05 Oct 2020 Planned primary completion date changed from 11 May 2022 to 1 Jul 2027.
- 26 Mar 2020 New trial record